Design of a multi-epitope vaccine candidate of gastric cancer against Helicobacter pylori

preprint OA: closed
View at publisher

Abstract

Background: Gastric cancer and peptic ulcers can both be caused by Helicobacter pylori ( H. pylori ). So the complexity of such bacterium made it difficult to develop an effective treatment. Thus, a computational approach to developing antigenicity, stability, and safety in vaccines against this pathogen will aid in the management of related diseases. Methods: : This investigation chose two H. pylori proteins, SabA and BabA, as epitope prediction targets. Therefore, this study used an immunoinformatics platform to create a subunit vaccine against H. pylori . The best helper T lymphocytes (HTLs) along with cytotoxic T lymphocytes (CTLs) epitopes have been chosen according to antigenicity, toxicity and allergenicity. The chosen epitopes, suitable linkers, as well as adjuvants were combined for creating a final vaccine design. The antigenicity, allergenicity, along with physicochemical traits of vaccine were assessed. Results: : The vaccine’s 3D structure has been anticipated. Molecular docking analysis along with molecular dynamics (MD) simulation were performed on multi-epitope vaccine. The vaccine candidate was in silico cloned in pET28a (+) vector. Conclusion: The results showed that final vaccine design would work well as an effective prophylactic vaccine versus H. pylori . To evaluate vaccine efficacy against the aforementioned bacteria, in vivo and in vitro trials are required.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00